An early regional experience with expansion of milan criteria for liver transplant recipients

American Journal of Transplantation

Volumn 10, Issue 9, 2010, Pages 2092-2098

  Guiteau, J J ^a   Cotton, R T ^a   Washburn, W K ^b   Harper, A ^c   O'Mahony, C A ^a   Sebastian, A ^d   Cheng, S ^e   Klintmalm, G ^f   Ghobrial, M ^g   Halff, G ^b   Mieles, L ^h   Goss, J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNITED NETWORK FOR ORGAN SHARING   (United States)

^d INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^e University of Texas SW Medical Ctr   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g HOUSTON METHODIST HOSPITAL   (United States)

^h MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

expanding Milan Criteria; hepatocellular carcinoma; liver transplantation; Milan Criteria

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH PROGRAM; HUMAN; ITALY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956152151     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03222.x     Document Type: Article

References (27)

1. Mazzaferro V, Chun YS, Poon RT et al. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008 15 : 1001 1007.
2. Duffy JP, Vardanian A, Benjamin E et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: A 22-year experience with 467 patients at UCLA. Ann Surg 2007 246 : 502 509.
3. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000 88 : 538 543.
4. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991 15 : 270 285.
5. Iwatsuki S, Starzl TE, Sheahan DG et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991 214 : 221 228.
6. Moreno P, Jaurrieta E, Figueras J et al. Orthotopic liver transplantation: Treatment of choice in cirrhotic patients with hepatocellular carcinoma? Transplant Proc 1995 27 : 2296 2298.
7. Van Thiel DH, Carr B, Iwatsuki S, Selby RR, Fung JJ, Starzl TE. The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991. J Surg Oncol Suppl 1993 3 : 78 82.
8. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334 : 693 699.
9. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007 7 : 2587 2596.
10. Fan J, Yang GS, Fu ZR et al. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: A multi-center experience in Shanghai, China. J Cancer Res Clin Oncol 2009 135 : 1403 1412.
11. Ravaioli M, Ercolani G, Cescon M et al. Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria. Liver Transpl 2004 10 : 1195 1202.
12. Shah SR. Living-related transplantation for hepatocellular carcinoma: How far do we travel beyond Milan? Indian J Gastroenterol 2008 27 : 139 141.
13. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007 13 : 391 399.
14. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009 49 : 832 838.
15. Herrero JI, Sangro B, Pardo F et al. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 2008 14 : 272 278.
16. Toso C, Kneteman NM, Shapiro JAM, Bigam DL. The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria. Transpl Int 2009 22 : 869 875.
17. Yao FY. Liver transplantation for hepatocellular carcinoma: Beyond the Milan criteria. Am J Transplant 2008 8 : 1982 1989.
18. Decaens T, Roudot-Thoraval F, Hadni-Bresson S et al. Impact of UCSF criteria according to pre-and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006 12 : 1761 1769.
19. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001 33 : 1394 1403.
20. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993 218 : 145 151.
21. Santoyo J, Suarez MA, Fernández-Aguilar JL et al. Liver transplant results for hepatocellular carcinoma applying strict preoperative selection criteria. Transplant Proc 2005 37 : 1488 1490.
22. Zavaglia C, De Carlis L, Alberti AB et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005 100 : 2708 2716.
23. Schumacher G, Oidtmann M, Rosewicz S et al. Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth. Transplant Proc 2002 34 : 1392 1393.
24. Schumacher G, Oidtmann M, Rueggeberg A et al. Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth. World J Gastroenterol 2005 11 : 1420 1425.
25. Toso C, Meeberg GA, Bigam DL et al. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side effects. Transplantation 2007 83 : 1162 1168.
26. Volk ML, Vijan S, Marrero JA. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008 8 : 839 846.
27. Pomfret EA, Washburn WK, Nalesnik MA et al. Report of a National Conference on Liver Allocation in Patients with Hepatocellular Carcinoma. Rep. Print.